The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer

References

• Schneider G, Siveke JT, Eckel F, Schmid RM. (2005). Pancreatic cancer: basic and clinical aspects. Gastroenterology 128:1606–25.
   PubMed Web of Science ®Google Scholar
• Geer RJ, Brennan MF, Cameron J, et al. (1993). Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68–73.
   PubMed Web of Science ®Google Scholar
• Nitecki SS, Sarr MG, Colby TV, van Heerden JA. (1995). Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66.
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Warshaw AL, Finlayson SRG, et al. (1999). Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 126:178–83.
   PubMed Web of Science ®Google Scholar
• Bramhall SR, Allum WH, Jones AG, et al. (1995). Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111–15.
   PubMed Web of Science ®Google Scholar
• Jemal A, Thomas A, Murray T, Thun M. (2002). Cancer statistics 2002. CA Cancer J Clin 52:23–47.
   PubMed Web of Science ®Google Scholar
• Beger HG, Rau B, Gansauge F, et al. (2008). Pancreatic cancer-low survival rates. Dtsch Arztebl Int 105:255–62.
   PubMed Web of Science ®Google Scholar
• Lim JE, Chien MW, Earle CC. (2003). Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85.
   PubMed Web of Science ®Google Scholar
• Cameron JL, Riall TS, Coleman J, Belcher KA. (2006). One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10–15.
   PubMed Web of Science ®Google Scholar
• Warshaw AL, Fernandez-del Castillo C. (1992). Pancreatic carcinoma. N Engl J Med 326:455–65.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1996). Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH, ed. Peritoneal carcinomatosis: principles and practise of management. Boston, MA: Kluwer Academic, 79–100.
   Google Scholar
• Tu Y, Tian Y, Fang Z, et al. (2016). Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study. Int J Hypertmermia 2016. [Epub ahead of print]. doi: 10.1080/02656736.2016.1190987.
   Google Scholar
• Yan TD, Black D, Savady R, Sugarbaker PH. (2006). A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14:484–92.
   PubMed Web of Science ®Google Scholar
• Yan TD, Welch L, Black D, Sugarbaker PH. (2007). A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 18:827–34.
   PubMed Web of Science ®Google Scholar
• Rossi CR, Deraco M, De Simone M, et al. (2004). Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 100:1943–50.
   PubMed Web of Science ®Google Scholar
• Bakrin N, Bereder JM, Decullier E, et al. (2013). From the FROGHI (French Oncologic and Gynaecologic HIPEC Group). EJSO 39:1435–43.
   PubMed Web of Science ®Google Scholar
• Randle RW, Swett KR, Shen P, et al. (2013). Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. Am Surg 79:620–4.
   PubMed Web of Science ®Google Scholar
• Polom K, Roviello G, Generali D, et al. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer. Int J Hyperthermia 32:298–310.
   PubMed Web of Science ®Google Scholar
• Ching Tan GH, Ong WS, Chia CS, et al. (2016). Does early postoperative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? Int J Hyperthermia 32:281–8.
   PubMed Web of Science ®Google Scholar
• Tentes AA, Kyziridis D, Kakolyris S, et al. (2012). Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in respectable pancreatic cancer. Gastroenterol Res Practise 2012:506571. doi: 10.1155/2012/506571.
   PubMed Web of Science ®Google Scholar
• Kalser MH, Ellenberg SS. (1985). Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903.
   PubMed Web of Science ®Google Scholar
• Klinkenbijl JH, Jeekel J, Sahmoud T, et al. (1999). Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776–84.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Stocken DD, Friess H, et al. (2004). A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–10.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Herman JM, Corsini MM, et al. (2010). Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins hospital-Mayo clinic collaborative study. Ann Surg Oncol 17:981–90.
   PubMed Web of Science ®Google Scholar
• Conroy T, Desseigne F, Ychou M, et al. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–25.
   PubMed Web of Science ®Google Scholar
• Von Hoff DP, Ramanathan RK, Borad MJ, et al. (2011). Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol 29:4548–55.
   PubMed Web of Science ®Google Scholar
• Koliopanos A, Avgerinos C, Farfaras A, et al. (2008). Radical resection of pancreatic cancer. HBPD Int 7:11–18.
   Google Scholar
• Ansari D, Gustafsson A, Andersson R. (2015). Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol 21:3157–65.
   Google Scholar
• Glehen O, Kwiatkowski F, Sugarbaker PH, et al. (2004). Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–92.
   PubMed Web of Science ®Google Scholar
• Dedrick RL. (1985). Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 12:1–6.
   PubMed Web of Science ®Google Scholar
• Speyer JL, Sugarbaker PH, Collins JM, et al. (1981). Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 41:1916–22.
   PubMed Web of Science ®Google Scholar
• Oettle H, Post S, Neuhaus P, et al. (2007). Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–77.
   PubMed Web of Science ®Google Scholar
• Ridwelski K, Meyer F, Hribaschek A, et al. (2002). Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurrence of peritoneal carcinomatosis. J Surg Oncol 79:10–16.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Stuart OA, Bijelic L. (2012). Intraperitoneal gemcitabine chemotherapy as an adjuvant treatment for patients with resected pancreatic cancer: phase II and pharmacologic studies. Transl Gastrointestin Cancer 1:161–8.
   Google Scholar
• Pestieau SR, Stuart OA, Chang D, et al. (1998). Pharmacokinetics of intraperitoneal gemcitabine in a rat model. Tumori 84:706–11.
   PubMed Web of Science ®Google Scholar
• Schwartz L, Votanopoulos K, Morris D, et al. (2016). Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? Results of an international multicenter study. Ann Surg 263:369–75.
   PubMed Web of Science ®Google Scholar
• Renz BW, Khalil PN, Mikhailov M, et al. (2016). Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: a retrospective cohort study. Int J Surg 28:118–25.
   PubMed Web of Science ®Google Scholar
• Wittel UA, Makowiec F, Sick O, et al. (2015). Retrospective analyses of trends in pancreatic surgery: indications, operative techniques, and postoperative outcome in 1120 pancreatic resections. World J Surg Oncol 13:102. doi: 10.1186/s12957-015-0525-6.
   PubMed Web of Science ®Google Scholar
• Benassai G, Mastrorilli M, Quarto G, et al. (2000). Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73:212–18.
   PubMed Web of Science ®Google Scholar
• Magistrelli P, Antinori A, Crucitti A, et al. (2000). Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74:36–40.
   PubMed Web of Science ®Google Scholar